Watch Now! Bitesize Learning: Anticoagulation in VTE
Our expert speaker Bunis Packham is a Nurse Consultant for Thrombosis and Anticoagulation in the Pathology Department of the Royal Free NHS Foundation Trust. In this fascinating bitesize video, she discusses Anticoagulation in VTE. Sign up to our Cardiovascular Series: Anticoagulation in VTE in Primary Care webinar to find out more.
Risk Factors for Anticoagulation in VTE
In our Bitesize video, Bunis discusses Virchow’s Triad. She touches on why we are seeing an increase in the number of incidents of VTE during the Covid-19 pandemic. The change in lifestyle caused by lockdown has made us all more immobile. Many of us sit at home working rather than tackling the daily commute.
Bunis goes on to talk about the increased risk of VTE caused by surgery and other trauma. She stresses the importance of making her own assessment of whether a clot is provoked or unprovoked. The patient’s history and type of clot give her an idea of how long the patient will need to be on anticoagulation therapy.
Treatment of Anticoagulation in VTE
Expert speaker Bunis Packham points out that anticoagulation therapy does not dissolve the clot. Instead, it prevents another clot. It also prevents the existing clot from growing. We are born with both a clotting mechanism and a mechanism that dissolves clots. Rapid anticoagulation therapy limits the damage and scarring caused by clots.
The implications of clots that are not treated quickly are discussed along with demonstrative images. Bunis explains deep vein thrombosis and pulmonary embolisms, and how anticoagulation therapy can help. She covers the importance of explaining things properly to patients so they can be involved in the decision making process. She also touches on renal functions and treatment calculations.
Further learning
The interactive nature of MORPh training webinars is obvious from listening to expert speaker Bunis Packham. She refers to questions set for candidates, delivering and explaining the answers. She also discusses real world cases to bring the learning to life.
Candidates who sign up to the Cardiovascular Series: Anticoagulation in VTE in Primary Care webinar can expect to hear Bunis discussing the following topics in detail:
- Pathophysiology of PVT and PE
- Provoked and unprovoked events explained
- Treatment pathways and the role of primary care
- New indications for anticoagulants and dose selection
- Risk assessment and the use of anticoagulants in VTE
- How to engage and manage VTE patients using a case based approach
- Interactive case studies
The webinar runs from 9.30 am to 1.00 pm on Thursday, 19th August 2021. It is FREE for all Primary Care, PCN, CCG and GP Pharmacists and Pharmacy Technicians based in Scotland, the North East of England and Northern Ireland. If you are based in a different geographical area or work in another healthcare profession, please get in touch with MORPh Training before registering for the webinar.
You can book your place on the Cardiovascular Series: Anticoagulation in VTE in Primary Care webinar via our website or get in touch with Jodie by email on jodie@morphconsultancy.co.uk or by telephone on 07538 554717.
